Skip to main navigation Skip to search Skip to main content

Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Early Breast Cancer Treatment and Outcomes by Risk of Recurrence: A Retrospective US Electronic Health Records Study

  • Reshma Mahtani
  • , Simon M. Collin
  • , Ziyu Tan
  • , Chintal H. Shah
  • , Basirat Adeyemi
  • , Sophie Davies
  • , Ellie John
  • , Gregory Vidal

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1848
JournalCancers
Volume17
Issue number11
DOIs
StatePublished - Jun 2025

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • adjuvant therapy
  • breast cancer
  • clinical outcomes
  • early stage
  • HER2-positive
  • high-risk
  • neoadjuvant therapy
  • observational study
  • secondary data
  • treatment patterns

Cite this